Page last updated: 2024-08-21

pyrazines and Lymphangiectasis

pyrazines has been researched along with Lymphangiectasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Connell, C; Schroyens, W; Sykes, DB1
Korde, N; Kwok, M; Landgren, O1

Other Studies

2 other study(ies) available for pyrazines and Lymphangiectasis

ArticleYear
The TEMPI syndrome--a novel multisystem disease.
    The New England journal of medicine, 2011, Aug-04, Volume: 365, Issue:5

    Topics: Adult; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Hydronephrosis; Lymphangiectasis; Male; Middle Aged; Paraproteinemias; Polycythemia; Protease Inhibitors; Pyrazines; Syndrome; Telangiectasis

2011
Bortezomib to treat the TEMPI syndrome.
    The New England journal of medicine, 2012, May-10, Volume: 366, Issue:19

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Lymphangiectasis; Middle Aged; Paraproteinemias; Polycythemia; Pyrazines; Syndrome; Telangiectasis

2012